Jane B. Knudsen
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Jane B. Knudsen has a total of 7 co-authors. Here are the top co-authors by number of shared publications:
Eskild Petersen
Department of Infectious Diseases, Aarhus University Hospital, Skejby, Aarhus, Denmark
3 shared publicationsHenrik Egeblad
Department of Cardiology, Aarhus University Hospital, Skejby, Aarhus, Denmark
3 shared publicationsKurt Fuursted
Department of Clinical Microbiology, Aarhus University Hospital, Skejby, Aarhus, Denmark
3 shared publicationsPer Wierup
Department of Cardiothoracic and Vascular Surgery, Aarhus University Hospital, Skejby, Aarhus, Denmark
3 shared publicationsSteen H. Poulsen
Department of Cardiology, Aarhus University Hospital, Skejby, Aarhus, Denmark
3 shared publicationsHenning Mølgaard
Department of Cardiology, Aarhus University Hospital, Skejby, Aarhus, Denmark
2 shared publications
Latest Publications
- 31 March 2011
- Published by Taylor & Francis in Scandinavian Cardiovascular Journal
- Vol. 45 (3) , 133-138
Failure of clinical features of low probability endocarditis. The early echo remains essential
Objective. To investigate if earlier reported retrospectively derived criteria for predicting absence of infective endocarditis (IE) on transthoracic echocardiography could be prospectively confirmed or improved with transoesophageal echocardiography (TOE). Design. Prospective analysis of the relationship between predefined clinical IE features and findings on TOE in 708 IE suspected patients. Results. The previously reported criteria were rejected as 1/10 of our confirmed IE patients fulfilled criteria for predicting absence of IE. However, our study generated another model of low probability of IE: This disease was absent in 99.4% of patients with negative blood cultures and absence of vascular phenomena and predisposing cardiac conditions. Such patients accounted for 25% of our population of patients suspected of IE. Conclusions. The utility of earlier reported clinical criteria for predicting absence of IE proved insufficient. Instead the study generated new simpler criteria of low probability of IE. However, these included negative blood cultures, but echocardiography must not be postponed while awaiting the results of blood cultures. Therefore the proposed new criteria only apply to patients with documented negative blood cultures when the suspicion of IE arises, in our study only 10% of the population. Accordingly, the study documented the essential role of early echocardiography in suspected IE.
- 31 March 2011
- Published by Taylor & Francis in Scandinavian Cardiovascular Journal
- Vol. 45 (3) , 133-138
Failure of clinical features of low probability endocarditis. The early echo remains essential
Objective. To investigate if earlier reported retrospectively derived criteria for predicting absence of infective endocarditis (IE) on transthoracic echocardiography could be prospectively confirmed or improved with transoesophageal echocardiography (TOE). Design. Prospective analysis of the relationship between predefined clinical IE features and findings on TOE in 708 IE suspected patients. Results. The previously reported criteria were rejected as 1/10 of our confirmed IE patients fulfilled criteria for predicting absence of IE. However, our study generated another model of low probability of IE: This disease was absent in 99.4% of patients with negative blood cultures and absence of vascular phenomena and predisposing cardiac conditions. Such patients accounted for 25% of our population of patients suspected of IE. Conclusions. The utility of earlier reported clinical criteria for predicting absence of IE proved insufficient. Instead the study generated new simpler criteria of low probability of IE. However, these included negative blood cultures, but echocardiography must not be postponed while awaiting the results of blood cultures. Therefore the proposed new criteria only apply to patients with documented negative blood cultures when the suspicion of IE arises, in our study only 10% of the population. Accordingly, the study documented the essential role of early echocardiography in suspected IE.
- 1 December 2010
- Published by Elsevier in The American Journal of Medicine
- Vol. 123 (12) , 1121-1127
Procalcitonin in 759 Patients Clinically Suspected of Infective Endocarditis
- 1 December 2010
- Published by Elsevier in The American Journal of Medicine
- Vol. 123 (12) , 1121-1127
Procalcitonin in 759 Patients Clinically Suspected of Infective Endocarditis
- 1 July 2009
- Vol. 18 (4) , 386-394
Infective Endocarditis: A Continuous Challenge. The Recent Experience of a European Tertiary Center
Background and aim of the study: The study aim was to monitor infective endocarditis (IE) before and after the condition was brought into focus in hospitals in the Aarhus region of Denmark. Methods: A total of 172 patients with IE, all of whom had been referred to the regional tertiary center during 2000-2001 or during 2005-2006, was included prospectively into the study. Results: Between 2000-1 (n = 51) and 2005-6 (n = 121), a very large (137%) increase occurred in the number of IE patients referred (p <0.01). Yet, over this period, the delay from onset of symptoms to admission remained at one month, with a further prolongation of one week (p <0.05) in 40% of patients who had received pre-hospital antibiotic treatment. A previous healthcare procedure was recorded in 37% of cases, with an ascending trend from 2000-1 to 2005-6. The increase in six-month mortality was high, from 16% to 26%, but was not statistically significant. Independent predictors were prosthetic valve IE (p = 0.02), advanced age (p = 0.03) and co-morbidity (p = 0.05); all three of these features increased over the five-year study interval. Conclusion: Although increased regional hospital attention to IE seemed to facilitate admission to the authors' center, this did not improve survival, apparently because of an unchanged admission delay and increasing age, comorbidity, and prosthetic valve IE. Delayed admission and health care-induced IE were susceptible to modification. Future measures should, therefore, be particularly focused on high-risk patients, on educating the general practitioners, and on improving access to primary healthcare facilities for blood culture and echocardiography.
- 1 July 2009
- Vol. 18 (4) , 386-394
Infective Endocarditis: A Continuous Challenge. The Recent Experience of a European Tertiary Center
Background and aim of the study: The study aim was to monitor infective endocarditis (IE) before and after the condition was brought into focus in hospitals in the Aarhus region of Denmark. Methods: A total of 172 patients with IE, all of whom had been referred to the regional tertiary center during 2000-2001 or during 2005-2006, was included prospectively into the study. Results: Between 2000-1 (n = 51) and 2005-6 (n = 121), a very large (137%) increase occurred in the number of IE patients referred (p <0.01). Yet, over this period, the delay from onset of symptoms to admission remained at one month, with a further prolongation of one week (p <0.05) in 40% of patients who had received pre-hospital antibiotic treatment. A previous healthcare procedure was recorded in 37% of cases, with an ascending trend from 2000-1 to 2005-6. The increase in six-month mortality was high, from 16% to 26%, but was not statistically significant. Independent predictors were prosthetic valve IE (p = 0.02), advanced age (p = 0.03) and co-morbidity (p = 0.05); all three of these features increased over the five-year study interval. Conclusion: Although increased regional hospital attention to IE seemed to facilitate admission to the authors' center, this did not improve survival, apparently because of an unchanged admission delay and increasing age, comorbidity, and prosthetic valve IE. Delayed admission and health care-induced IE were susceptible to modification. Future measures should, therefore, be particularly focused on high-risk patients, on educating the general practitioners, and on improving access to primary healthcare facilities for blood culture and echocardiography.